Format

Send to

Choose Destination
Clin Pharmacol Ther. 2014 Aug;96(2):158. doi: 10.1038/clpt.2014.90. Epub 2014 Apr 22.

Response to "evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity".

Author information

1
1] Child and Family Research Institute, Vancouver, British Columbia, Canada [2] Division of Translational Therapeutics, Department of Pediatrics, The University of British Columbia, Vancouver, British Columbia, Canada [3] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada.
2
1] Child and Family Research Institute, Vancouver, British Columbia, Canada [2] Division of Translational Therapeutics, Department of Pediatrics, The University of British Columbia, Vancouver, British Columbia, Canada [3] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada [4] Centre for Molecular Medicine and Therapeutics; Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada.
3
1] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada [2] Centre for Molecular Medicine and Therapeutics; Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada.
4
1] Child and Family Research Institute, Vancouver, British Columbia, Canada [2] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada [3] Centre for Molecular Medicine and Therapeutics; Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada.
5
Department of Pediatrics, Amalia Children's Hospital, Radboud University Medical Centre, Nijmegen, The Netherlands.
6
1] Child and Family Research Institute, Vancouver, British Columbia, Canada [2] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada [3] Division of Pediatric Hematology/Oncology/Bone Marrow Transplant, Department of Pediatrics, BC Children's Hospital, Vancouver, British Columbia, Canada.
7
Centre for Molecular Medicine and Therapeutics; Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada.
PMID:
24755913
DOI:
10.1038/clpt.2014.90
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center